Etomidate

FDA Approved: * November 4, 1996
Pharm Company: * BEDFORD
Category: Anesthetic

Etomidate[1] (USAN, INN, BAN; marketed as Amidate) is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation[2] for short procedures such as reduction of dislocated joints, tracheal intubation, cardioversion and electroconvulsive therapy. It was developed at Janssen Pharmaceutica in 1964 and was introduced as an intravenous agent in 1972 in Europe and in 1983 in the United States.[3] The most comm... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Etomidate 2 mg/ml Intravenous Injection
NDC: 0069-0006
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Etomidate 2 mg/ml Intravenous Injection
NDC: 0143-9310
Labeler:
West-ward Pharmaceuticals Corp
Etomidate 2 mg/ml Intravenous Injection
NDC: 0143-9311
Labeler:
West-ward Pharmaceuticals Corp
Etomidate 2 mg/ml Intravenous Injection
NDC: 0143-9506
Labeler:
West-ward Pharmaceuticals Corp
Etomidate 2 mg/ml Intravenous Injection
NDC: 0143-9507
Labeler:
West-ward Pharmaceuticals Corp
Etomidate 2 mg/ml Intravenous Injection, Solution
NDC: 0517-0780
Labeler:
American Regent, Inc.
Etomidate 2 mg/ml Intravenous Injection, Solution
NDC: 0517-0781
Labeler:
American Regent, Inc.
Etomidate 2 mg/ml Intravenous Injection
NDC: 23155-160
Labeler:
Heritage Pharmaceuticals Inc.
Etomidate 2 mg/ml Intravenous Injection
NDC: 23155-522
Labeler:
Heritage Pharmaceuticals Inc.
Etomidate 2 mg/ml Intravenous Injection, Solution
NDC: 25021-674
Labeler:
Sagent Pharmaceuticals

Related Brands

Drugs with the same active ingredients

Popular Topics

etomidate

sedative...